Category: biotech

.After antibody-drug conjugate (ADC) professional Seagen was marketed to Pfizer in 2014 for a monstrous $43 billion, former chief executive officer David Epstein mentioned he

.Among the genetic medications branches race, Flagship Pioneering is actually introducing a brand-new firm to help biotechs make improvements the preciseness of their therapies.The endeavor

.Fierce Biotech Affiliate Publisher Gabrielle Masson provided the 2024 course of Brutal 15 winners on the flooring of the Stock exchange on Wednesday.Masson looked on

.Let’s study a conversation with Ayla Ellison, Fierce Biotech Managing Editor and also Michelle Benz as they explain the highlights and pleasure neighboring this year’s

.FibroGen is actually drastically reorganizing its own service, laying off 75% of its own united state personnel and also quiting investment in its own lead

.After F2G’s very first effort to receive a brand-new course of antifungal to market was actually hindered by the FDA, the U.K.-based biotech has gotten

.The FDA has actually executed a predisposed hold on a period 3 non-small cell bronchi cancer cells dry run through BioNTech as well as OncoC4

.The FDA has placed Kezar Life Sciences’ lupus test on grip after the biotech flagged 4 fatalities in the course of the phase 2b research.Kezar

.After pushing back the choice date for Applied Therapeutics’ metabolic condition medication govorestat, the FDA has currently determined that a planned advising committee meeting will

.For Lykos Therapies as well as the provider’s prospective MDMA-assisted treatment for post-traumatic stress disorder (PTSD), the hits only keep coming..Earlier this month, Lykos was